Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Healthcare getting its head in the cloud, cautiously

Nearly all mid-size healthcare organizations are using cloud computing or considering it, but almost two-thirds continue to have doubts about security.

Slow growth expected for worldwide nuclear imaging market

The global market for nuclear imaging technology is forecasted to reach $2.2 billion in 2020, just a 3.3 percent compound annual growth rate over the $1.83 billion noted for 2013, according to a December 2014 report by GlobalData.

Thumbnail

Watch neurons fire with fluorescence imaging

Fluorescent lights depict the electrical firing of neurons in the brain in this striking video demonstration reported by Bloomberg. The technology was developed by Adam E. Cohen, PhD, a Harvard neuroscientist and professor of chemical biology and physics.

Additional PET/CT alters treatment, predicts survival for certain cancer patients

Oral cavity squamous cell carcinoma is a painful and debilitating cancer. Another PET/CT after surgery and before adjuvant therapy could improve survival for these patients, according to a study published in the Journal of Nuclear Medicine.

Thumbnail

Neuroimaging in art

Every week, Molecular Imaging brings hard-hitting neuroimaging research to light, but today we are highlighting the unorthodox work of one neuroscientist—his paintings, in fact, which depict the microstructure of the brain.

Deadline for SNMMI governmental fellowship approaches

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Robert E. Henkin Fellowship is an annual opportunity for nuclear medicine and molecular imaging professionals just starting out in their careers and are involved closely in government relations.

Thumbnail

Treatment for a neurological disorder in children is all in the genes

A protein called neurofibromin and a competing pathway could be the ticket to a novel gene therapy for a rare pediatric disorder called neurofibromatosis, which is associated with autism and learning difficulties. The proposed therapy could reverse these symptoms, announced officials from the University of Texas (UT) Southwestern on Monday.

Thumbnail

More than $1.1M goes to Worcester Polytechnic for a revamped nuclear program

Four generous grants from the U.S. Nuclear Regulatory Commission (NRC) have been bestowed on the Worcester Polytechnic Institute in Worcester, Mass., institute officials announced today.